![](https://www.elaia.com/wp-content/uploads/2020/05/LOGO_TPX.jpeg)
Towards automation of breast cancer screening
Entrepreneurs
Matthieu Leclerc-Chalvet
Pierre Fillard
Elaia Team
Related articles
![](https://www.elaia.com/wp-content/uploads/2019/01/Screenshot-2020-07-15-at-09.18.01.png)
The Company will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States
2022.05.12 / 3min read.
![](https://www.elaia.com/wp-content/uploads/2019/01/Screenshot-2020-07-15-at-09.18.01.png)
MammoScreenTM, the explainable and actionable artificial intelligence (AI) based software assisting Radiologists in reading screening mammograms, received 510(k) clearance K192854 from the U.S. Food and Drug Administration (FDA).
2020.07.09 / 3min read.